Literature DB >> 21319315

Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology.

Zahra Maleki1.   

Abstract

Basaloid squamous cell carcinoma (BSQCC) and high-grade neuroendocrine carcinomas (HGNEC) including small cell carcinoma (SMCC) and large cell neuroendocrine carcinoma (LCNEC) can be difficult to differentiate on lung cytology. This problem is particularly true in scant specimens where immunoperoxidase stains cannot be adequately performed. Sixty-six cases of BSQCC, LCNEC, and SMCC (22 cases of each) on lung or mediastinal cytology were retrospectively reviewed from the cytopathology archives of two hospitals. Common cytomorphologic characteristics were; hypercellularity, small to intermediate round blue (hyperchromatic) cells, lack of prominent nucleoli, lack of three dimensional architecture, karyorrhexis/necrosis, mitoses, naked nuclei, nuclear crush artifact, and nuclear molding. Distinctive features included: larger cell size with pleomorphism, more cohesive architecture, syncytial aggregation, slightly coarser chromatin texture, rare keratinized malignant cells, and a granular smear background seen more often in BSQCC as opposed to HGNEC. Larger cells with prominent nucleoli and more cytoplasm with focal rosette formation were helpful in distinguishing LCNEC from SMCC and BSQCC. Finally, SMCC displayed uniform small cells with extensive necrosis, and higher mitotic rate. Immunoperoxidase (IPOX) staining using p63, CK5, 6, neuroendocrine markers (chromogranin, synaptophysin and CD56) and TTF-1 were helpful. BSQCC showed p63 expression and was mostly negative for neuroendocrine markers and TTF-1. HGNEC showed immunoreactivity for neuroendocrine markers with variable immunoreactivity for TTF-1. BSQCC, SMCC, and LCNEC share overlapping cytomorphologic features and can be difficult to differentiate on limited cytology specimens. Careful consideration to subtle but definite cytomorphologic clues and attention to selective IPOX stains can lead to a definitive diagnosis.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21319315     DOI: 10.1002/dc.21351

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  8 in total

Review 1.  Treatment of lung large cell neuroendocrine carcinoma.

Authors:  Giuseppe Lo Russo; Sara Pusceddu; Claudia Proto; Marianna Macerelli; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Rosaria Gallucci; Nicoletta Zilembo; Marco Platania; Roberto Buzzoni; Filippo de Braud; Marina Chiara Garassino
Journal:  Tumour Biol       Date:  2016-03-04

2.  Large cell neuroendocrine carcinoma: topic review and a unique case of metastasis to the mandible.

Authors:  Keith M Schneider; Alan Y Martinez; Marcello Guglielmi
Journal:  J Maxillofac Oral Surg       Date:  2012-04-29

3.  Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma.

Authors:  Kianoosh Keyhanian; William J Phillips; Benjamin S Yeung; Marcio Gomes; Bryan Lo; Harmanjatinder S Sekhon
Journal:  Diagn Pathol       Date:  2022-05-10       Impact factor: 3.196

Review 4.  Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors.

Authors:  Rita Dorantes-Heredia; José Manuel Ruiz-Morales; Fernando Cano-García
Journal:  Transl Lung Cancer Res       Date:  2016-08

5.  Repeated occurrence of second primary lung cancer at different sites in trachea: a case report.

Authors:  Yong Chul Lee; Yun Ji Park; Su Jin Gang; Myung Ja Chung; So Ri Kim
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 6.  Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis.

Authors:  Marina K Baine; Natasha Rekhtman
Journal:  Transl Lung Cancer Res       Date:  2020-06

Review 7.  Survival outcomes of surgery in patients with pulmonary large-cell neuroendocrine carcinoma: a retrospective single-institution analysis and literature review.

Authors:  Yeye Chen; Jiaqi Zhang; Cheng Huang; Zhenhuan Tian; Xiaoyun Zhou; Chao Guo; Hongsheng Liu; Shanqing Li
Journal:  Orphanet J Rare Dis       Date:  2021-02-12       Impact factor: 4.123

Review 8.  [Advances in Molecular Biomarker for Pulmonary Large Cell Neuroendocrine Carcinoma].

Authors:  Jinyao Zhang; Lin Yang; Junling Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.